Your browser version is outdated. We recommend that you update your browser to the latest version.

DeNovX is ...

de novo

/di ˈnōvō/

Adverb, Latin origin.

Starting from the beginning; anew.


DeNovX’s management team has extensive experience in drug development, research, commercialization and management that it is focusing on the advancement of new technologies to improve human lives.  It is doing this through the development of a new therapy for ulcerative colitis targeted at those patients in urgent need of an alternative to currently approved drugs that are often ineffective, expensive, inconvenient to administer and/or possess significantly potential side effects.  It is also doing this through the development of new crystal screening and manufacturing methods to increase the efficiency and reduce the cost and time required to develop new small molecule therapies.